New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
S. Korea stem cell scandal official resigns

S. Korea stem cell scandal official resigns

Park Ki-Young stepped down as the head of a newly-created science centre, which is responsible for allocating $18 billion in government subsidies and budgets for research projects, a blow to President
World medicine November 30,2023
S. Korea stem cell scandal official resigns

S. Korea stem cell scandal official resigns

Park Ki-Young stepped down as the head of a newly-created science centre, which is responsible for allocating $18 billion in government subsidies and budgets for research projects, a blow to President
World medicine November 30,2023
Photo-responsive protein hydrogels as agent for controlled stem cell/protein release

Photo-responsive protein hydrogels as agent for controlled stem cell/protein release

by Hong Kong University of Science and TechnologyMaterial design empowered by protein sequence space. Credit: Department of Chemical and Biological Engineering, HKUSTHydrogels, noted for their biomime
World medicine November 30,2023
Photo-responsive protein hydrogels as agent for controlled stem cell/protein release

Photo-responsive protein hydrogels as agent for controlled stem cell/protein release

by Hong Kong University of Science and TechnologyMaterial design empowered by protein sequence space. Credit: Department of Chemical and Biological Engineering, HKUSTHydrogels, noted for their biomime
World medicine November 30,2023
Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

by Tokyo Metropolitan University(top) Intracellular localization of RUNX2 and YAP in MSCs on gelatin gels with different elastic moduli. Notice how more signal is seen in a single location (the nucleu
World medicine November 30,2023
Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

Finer touch for tuning stem cell 'fate' with substrates of varying stiffness

by Tokyo Metropolitan University(top) Intracellular localization of RUNX2 and YAP in MSCs on gelatin gels with different elastic moduli. Notice how more signal is seen in a single location (the nucleu
World medicine November 30,2023
The start of a new era in stem cell therapy

The start of a new era in stem cell therapy

byKoc UniversityCredit: Koc UniversityA recent study published in the April 8 issue ofNature Chemical Biologyimproves on the "Cellular Reprogramming" method developed by No
World medicine November 30,2023
The start of a new era in stem cell therapy

The start of a new era in stem cell therapy

byKoc UniversityCredit: Koc UniversityA recent study published in the April 8 issue ofNature Chemical Biologyimproves on the "Cellular Reprogramming" method developed by No
World medicine November 30,2023
Combining potent cancer drugs in a single multitargeting molecule

Combining potent cancer drugs in a single multitargeting molecule

byWileyCredit: PtIVprodrug (2) can release Gem, Oxal, and Dox in their active form upon cellular reduction. It effectively induces release of ICD markers, DAMPs (CALR, ATP & HMGB1) in
World medicine November 30,2023
Combining potent cancer drugs in a single multitargeting molecule

Combining potent cancer drugs in a single multitargeting molecule

byWileyCredit: PtIVprodrug (2) can release Gem, Oxal, and Dox in their active form upon cellular reduction. It effectively induces release of ICD markers, DAMPs (CALR, ATP & HMGB1) in
World medicine November 30,2023
Stem cells moonlight to protect the stomach from bacterial invaders

Stem cells moonlight to protect the stomach from bacterial invaders

byMax Planck SocietyCross-section through the gastric mucosa of a mouse: Helicobacter pylori bacteria (green) colonize the cavities of the gastric glands. The nuclei of the mucous membrane cells
World medicine November 30,2023
Stem cells moonlight to protect the stomach from bacterial invaders

Stem cells moonlight to protect the stomach from bacterial invaders

byMax Planck SocietyCross-section through the gastric mucosa of a mouse: Helicobacter pylori bacteria (green) colonize the cavities of the gastric glands. The nuclei of the mucous membrane cells
World medicine November 30,2023
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

byPublic Library of ScienceHow chemotherapy awakens dormant cancer cells (on the left) resulting in tumor outgrowth (on the right). Credit:PLoS Biology(2023). DOI: 10.1371/journal.pb
World medicine November 30,2023
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells

byPublic Library of ScienceHow chemotherapy awakens dormant cancer cells (on the left) resulting in tumor outgrowth (on the right). Credit:PLoS Biology(2023). DOI: 10.1371/journal.pb
World medicine November 30,2023
Stem cell researchers reactivate 'back-up genes' in the lab

Stem cell researchers reactivate 'back-up genes' in the lab

byKU LeuvenMost female mammals have two X chromosomes, but only one of these is active in any given cell. In the images above, the yellow arrows point to the inactive X chromosome. DNA is shown
World medicine November 30,2023
Stem cell researchers reactivate 'back-up genes' in the lab

Stem cell researchers reactivate 'back-up genes' in the lab

byKU LeuvenMost female mammals have two X chromosomes, but only one of these is active in any given cell. In the images above, the yellow arrows point to the inactive X chromosome. DNA is shown
World medicine November 30,2023
Stem cells provide hope for dwindling wildlife populations

Stem cells provide hope for dwindling wildlife populations

byZoological Society of San DiegoCredit: CC0 Public DomainA paper recently published in the scientific journalStem Cells and Developmentshares an important advancement in conservatio
World medicine November 30,2023
Stem cells provide hope for dwindling wildlife populations

Stem cells provide hope for dwindling wildlife populations

byZoological Society of San DiegoCredit: CC0 Public DomainA paper recently published in the scientific journalStem Cells and Developmentshares an important advancement in conservatio
World medicine November 30,2023
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

by Eric Horvath,Perelman School of Medicine at the University of PennsylvaniaCell type and lack of substructure association of vector DNA and RNA following i.v. administration of AAV vectors to
World medicine November 30,2023
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations

by Eric Horvath,Perelman School of Medicine at the University of PennsylvaniaCell type and lack of substructure association of vector DNA and RNA following i.v. administration of AAV vectors to
World medicine November 30,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com